Yi-Wei Huang

8PUBLICATIONS
4CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunitySolid tumoursPacific Peoples cultural determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 27, 2023
Deficiency of interleukin-36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan.

Chang-Yu Hsieh, Yi-Wei Huang, Yi-Hsuan Huang

|Jul 18, 2022
Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled trials: a 15-year single-center experience.

Chen-Pu Yeh, Yi-Wei Huang, Tsen-Fang Tsai

|Jun 29, 2022
Ethambutol-induced subacute cutaneous lupus erythematosus.

Yi-Wei Huang, Wei-Hsin Wu

|Apr 06, 2022
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review.

Cho-Hsun Hsieh, Yi-Wei Huang, Tsen-Fang Tsai

|Jan 18, 2021
HLA-Cw1 and Psoriasis.

Yi-Wei Huang, Tsen-Fang Tsai

|Feb 27, 2020
A drug safety evaluation of risankizumab for psoriasis.

Yi-Wei Huang, Tsen-Fang Tsai

Pageof 2

Frequent Collaborators

5 joint publications

Tsen-Fang Tsai

1 joint publications

Cho-Hsun Hsieh

1 joint publications

Chang-Yu Hsieh

1 joint publications

Yi-Hsuan Huang